GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco on Tuesday, April 10 at 9:00 a.m. Central European Time.

The presentation will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBTGBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:Myesha Lacy (investors)GBT650-351-4730[email protected] 

Julie Normart (media)W2O pure415-946-1087[email protected]

Source: Global Blood Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Small Essential, Big Difference: How Modofo Makes Everyday Drinkware More Stylish
• Air Today Heating & Cooling Named South Carolina’s Best HVAC Sales and Service Company for the Second Year in a Row
• ComEd Debuts Mobile Assistance Unit at Waukegan Resource Fair, Bringing On-Site Bill Help Directly to Customers